Linscomb & Williams Inc. cut its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 2.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,427 shares of the biopharmaceutical company’s stock after selling 265 shares during the quarter. Linscomb & […]
Galapagos (NASDAQ:GLPG – Get Free Report) and Ardelyx (NASDAQ:ARDX – Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, risk, earnings, analyst recommendations, dividends and valuation. Analyst Recommendations This is a summary of current ratings […]
Innate Pharma (OTCMKTS:IPHYF – Get Free Report) and Gritstone bio (NASDAQ:GRTS – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, dividends, valuation and analyst recommendations. Valuation and Earnings This table compares Innate […]
Commerce Bank raised its stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 0.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 64,218 shares of the biopharmaceutical company’s stock after acquiring an additional 203 shares during the quarter. Commerce Bank’s […]
AXS Investments LLC lowered its position in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 12.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,050 shares of the biopharmaceutical company’s stock after selling 295 shares during the period. AXS Investments LLC’s […]